Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems

Nanotechnology. 2024 Jan 10;35(13). doi: 10.1088/1361-6528/ad170b.

Abstract

Chemotherapy is an important cancer treatment modality, but the clinical utility of chemotherapeutics is limited by their toxic side effects, inadequate distribution and insufficient intracellular concentrations. Nanodrug delivery systems (NDDSs) have shown significant advantages in cancer diagnosis and treatment. Variable NDDSs that respond to endogenous and exogenous triggers have attracted much research interest. Here, we summarized nanomaterials commonly used for tumor therapy, such as peptides, liposomes, and carbon nanotubes, as well as the responses of NDDSs to pH, enzymes, magnetic fields, light, and multiple stimuli. Specifically, well-designed NDDSs can change in size or morphology or rupture when induced by one or more stimuli. The varying responses of NDDSs to stimulation contribute to the molecular design and development of novel NDDSs, providing new ideas for improving drug penetration and accumulation, inhibiting tumor resistance and metastasis, and enhancing immunotherapy.

Keywords: enzyme; morphology change; nanodelivery system; pH; size variation.

Publication types

  • Review

MeSH terms

  • Humans
  • Immunotherapy
  • Nanoparticle Drug Delivery System
  • Nanoparticles*
  • Nanotubes, Carbon*
  • Neoplasms* / drug therapy

Substances

  • Nanotubes, Carbon
  • Nanoparticle Drug Delivery System